Aligned with suppressed AGXT and enhanced LDHA activity, oxalate concentrations assessed using an enzymatic method were significantly increased in livers from patients with MASH compared with controls (Fig. 1g). Here, AGXT is linked to metabolic dysfunction-associated steatohepatitis.